NCT04392297View on ClinicalTrials.gov

Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
CMV
Interventions
DIAGNOSTIC_TEST

Bood leukocyte subsets

Determination of blood leukocyte subpopulations: myeloid suppressor cells, T-regulatory cells, T-cells according to the stages of differentiation (naive - effector - memory), activated T-cells; circulating endothelial cells

DIAGNOSTIC_TEST

CMV specific T-cells

CMV specific T-cells detected by flow cytometry

DIAGNOSTIC_TEST

serum CMV IgM / IgG antibodies

serum CMV IgM / IgG antibodies detected by ELISA

Trial Locations (1)

220114

The Republican Research and Practical Center for Epidemiology and Microbiology, Minsk

All Listed Sponsors
collaborator

Belarusian State Medical University

OTHER

lead

The Republican Research and Practical Center for Epidemiology and Microbiology

OTHER

NCT04392297 - Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals | Biotech Hunter | Biotech Hunter